Recombinant Human Growth Hormone (HGH) is a bioactive protein intended for use in cell culture applications. HGH is a hormone with multiple effects. HGH is a pleiotropic molecule that binds the GH receptor. Recombinant Human Growth Hormone (HGH) is one of our more than 250 available Gibco庐 recombinant proteins.
The global Recombinant Human Growth Hormone market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Recombinant Human Growth Hormone is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Recombinant Human Growth Hormone is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Recombinant Human Growth Hormone is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Recombinant Human Growth Hormone include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F.Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen and LG Life Sciences, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Recombinant Human Growth Hormone, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Recombinant Human Growth Hormone, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Recombinant Human Growth Hormone, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Human Growth Hormone sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant Human Growth Hormone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Recombinant Human Growth Hormone sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Eli Lilly
Merck Serono
F.Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
BioPartners
Segment by Type
Powder
Solvent
Segment by Application
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Recombinant Human Growth Hormone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Recombinant Human Growth Hormone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Growth Hormone sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Recombinant Human Growth Hormone Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Recombinant Human Growth Hormone 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Powder
1.2.3 Solvent
1.3 麻豆原创 by Application
1.3.1 Global Recombinant Human Growth Hormone 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Growth Hormone Deficiency (GHD)
1.3.3 Turner Syndrome
1.3.4 Chronic Renal Insufficiency
1.3.5 Prader Willi Syndrome
1.3.6 Small for Gestational Age
1.3.7 SHOX Deficiency
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Growth Hormone Sales Estimates and Forecasts 2019-2030
2.2 Global Recombinant Human Growth Hormone Revenue by Region
2.2.1 Global Recombinant Human Growth Hormone Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Recombinant Human Growth Hormone Revenue by Region (2019-2024)
2.2.3 Global Recombinant Human Growth Hormone Revenue by Region (2025-2030)
2.2.4 Global Recombinant Human Growth Hormone Revenue 麻豆原创 Share by Region (2019-2030)
2.3 Global Recombinant Human Growth Hormone Sales Estimates and Forecasts 2019-2030
2.4 Global Recombinant Human Growth Hormone Sales by Region
2.4.1 Global Recombinant Human Growth Hormone Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Recombinant Human Growth Hormone Sales by Region (2019-2024)
2.4.3 Global Recombinant Human Growth Hormone Sales by Region (2025-2030)
2.4.4 Global Recombinant Human Growth Hormone Sales 麻豆原创 Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant Human Growth Hormone Sales by Manufacturers
3.1.1 Global Recombinant Human Growth Hormone Sales by Manufacturers (2019-2024)
3.1.2 Global Recombinant Human Growth Hormone Sales 麻豆原创 Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Growth Hormone in 2023
3.2 Global Recombinant Human Growth Hormone Revenue by Manufacturers
3.2.1 Global Recombinant Human Growth Hormone Revenue by Manufacturers (2019-2024)
3.2.2 Global Recombinant Human Growth Hormone Revenue 麻豆原创 Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Growth Hormone Revenue in 2023
3.3 Global Key Players of Recombinant Human Growth Hormone, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Recombinant Human Growth Hormone Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Human Growth Hormone 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Human Growth Hormone, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Human Growth Hormone, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Human Growth Hormone, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Recombinant Human Growth Hormone Sales by Type
4.1.1 Global Recombinant Human Growth Hormone Historical Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Growth Hormone Forecasted Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Growth Hormone Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Recombinant Human Growth Hormone Revenue by Type
4.2.1 Global Recombinant Human Growth Hormone Historical Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Growth Hormone Forecasted Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Growth Hormone Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Recombinant Human Growth Hormone Price by Type
4.3.1 Global Recombinant Human Growth Hormone Price by Type (2019-2024)
4.3.2 Global Recombinant Human Growth Hormone Price Forecast by Type (2025-2030)
5 麻豆原创 Size by Application
5.1 Global Recombinant Human Growth Hormone Sales by Application
5.1.1 Global Recombinant Human Growth Hormone Historical Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Growth Hormone Forecasted Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Growth Hormone Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Recombinant Human Growth Hormone Revenue by Application
5.2.1 Global Recombinant Human Growth Hormone Historical Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Growth Hormone Forecasted Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Growth Hormone Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Recombinant Human Growth Hormone Price by Application
5.3.1 Global Recombinant Human Growth Hormone Price by Application (2019-2024)
5.3.2 Global Recombinant Human Growth Hormone Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Recombinant Human Growth Hormone 麻豆原创 Size by Type
6.1.1 US & Canada Recombinant Human Growth Hormone Sales by Type (2019-2030)
6.1.2 US & Canada Recombinant Human Growth Hormone Revenue by Type (2019-2030)
6.2 US & Canada Recombinant Human Growth Hormone 麻豆原创 Size by Application
6.2.1 US & Canada Recombinant Human Growth Hormone Sales by Application (2019-2030)
6.2.2 US & Canada Recombinant Human Growth Hormone Revenue by Application (2019-2030)
6.3 US & Canada Recombinant Human Growth Hormone 麻豆原创 Size by Country
6.3.1 US & Canada Recombinant Human Growth Hormone Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Recombinant Human Growth Hormone Sales by Country (2019-2030)
6.3.3 US & Canada Recombinant Human Growth Hormone Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant Human Growth Hormone 麻豆原创 Size by Type
7.1.1 Europe Recombinant Human Growth Hormone Sales by Type (2019-2030)
7.1.2 Europe Recombinant Human Growth Hormone Revenue by Type (2019-2030)
7.2 Europe Recombinant Human Growth Hormone 麻豆原创 Size by Application
7.2.1 Europe Recombinant Human Growth Hormone Sales by Application (2019-2030)
7.2.2 Europe Recombinant Human Growth Hormone Revenue by Application (2019-2030)
7.3 Europe Recombinant Human Growth Hormone 麻豆原创 Size by Country
7.3.1 Europe Recombinant Human Growth Hormone Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Recombinant Human Growth Hormone Sales by Country (2019-2030)
7.3.3 Europe Recombinant Human Growth Hormone Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant Human Growth Hormone 麻豆原创 Size
8.1.1 China Recombinant Human Growth Hormone Sales (2019-2030)
8.1.2 China Recombinant Human Growth Hormone Revenue (2019-2030)
8.2 China Recombinant Human Growth Hormone 麻豆原创 Size by Application
8.2.1 China Recombinant Human Growth Hormone Sales by Application (2019-2030)
8.2.2 China Recombinant Human Growth Hormone Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Recombinant Human Growth Hormone 麻豆原创 Size by Type
9.1.1 Asia Recombinant Human Growth Hormone Sales by Type (2019-2030)
9.1.2 Asia Recombinant Human Growth Hormone Revenue by Type (2019-2030)
9.2 Asia Recombinant Human Growth Hormone 麻豆原创 Size by Application
9.2.1 Asia Recombinant Human Growth Hormone Sales by Application (2019-2030)
9.2.2 Asia Recombinant Human Growth Hormone Revenue by Application (2019-2030)
9.3 Asia Recombinant Human Growth Hormone Sales by Region
9.3.1 Asia Recombinant Human Growth Hormone Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Recombinant Human Growth Hormone Revenue by Region (2019-2030)
9.3.3 Asia Recombinant Human Growth Hormone Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant Human Growth Hormone 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Human Growth Hormone Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Recombinant Human Growth Hormone Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Recombinant Human Growth Hormone 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Human Growth Hormone Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Recombinant Human Growth Hormone Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Recombinant Human Growth Hormone Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant Human Growth Hormone Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Recombinant Human Growth Hormone Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Recombinant Human Growth Hormone Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Recombinant Human Growth Hormone Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Novo Nordisk Recombinant Human Growth Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Recombinant Human Growth Hormone Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Pfizer Recombinant Human Growth Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Recombinant Human Growth Hormone Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Eli Lilly Recombinant Human Growth Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Merck Serono
11.4.1 Merck Serono Company Information
11.4.2 Merck Serono Overview
11.4.3 Merck Serono Recombinant Human Growth Hormone Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Merck Serono Recombinant Human Growth Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Serono Recent Developments
11.5 F.Hoffmann-La Roche
11.5.1 F.Hoffmann-La Roche Company Information
11.5.2 F.Hoffmann-La Roche Overview
11.5.3 F.Hoffmann-La Roche Recombinant Human Growth Hormone Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 F.Hoffmann-La Roche Recombinant Human Growth Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 F.Hoffmann-La Roche Recent Developments
11.6 Ferring Pharmaceuticals
11.6.1 Ferring Pharmaceuticals Company Information
11.6.2 Ferring Pharmaceuticals Overview
11.6.3 Ferring Pharmaceuticals Recombinant Human Growth Hormone Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Ferring Pharmaceuticals Recombinant Human Growth Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ferring Pharmaceuticals Recent Developments
11.7 GeneScience Pharmaceuticals
11.7.1 GeneScience Pharmaceuticals Company Information
11.7.2 GeneScience Pharmaceuticals Overview
11.7.3 GeneScience Pharmaceuticals Recombinant Human Growth Hormone Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 GeneScience Pharmaceuticals Recombinant Human Growth Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GeneScience Pharmaceuticals Recent Developments
11.8 Ipsen
11.8.1 Ipsen Company Information
11.8.2 Ipsen Overview
11.8.3 Ipsen Recombinant Human Growth Hormone Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Ipsen Recombinant Human Growth Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ipsen Recent Developments
11.9 LG Life Sciences
11.9.1 LG Life Sciences Company Information
11.9.2 LG Life Sciences Overview
11.9.3 LG Life Sciences Recombinant Human Growth Hormone Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 LG Life Sciences Recombinant Human Growth Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 LG Life Sciences Recent Developments
11.10 Sandoz International
11.10.1 Sandoz International Company Information
11.10.2 Sandoz International Overview
11.10.3 Sandoz International Recombinant Human Growth Hormone Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Sandoz International Recombinant Human Growth Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sandoz International Recent Developments
11.11 Anhui Anke Biotechnology
11.11.1 Anhui Anke Biotechnology Company Information
11.11.2 Anhui Anke Biotechnology Overview
11.11.3 Anhui Anke Biotechnology Recombinant Human Growth Hormone Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Anhui Anke Biotechnology Recombinant Human Growth Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Anhui Anke Biotechnology Recent Developments
11.12 BioPartners
11.12.1 BioPartners Company Information
11.12.2 BioPartners Overview
11.12.3 BioPartners Recombinant Human Growth Hormone Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 BioPartners Recombinant Human Growth Hormone Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BioPartners Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Growth Hormone Industry Chain Analysis
12.2 Recombinant Human Growth Hormone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Growth Hormone Production Mode & Process
12.4 Recombinant Human Growth Hormone Sales and 麻豆原创ing
12.4.1 Recombinant Human Growth Hormone Sales Channels
12.4.2 Recombinant Human Growth Hormone Distributors
12.5 Recombinant Human Growth Hormone Customers
13 麻豆原创 Dynamics
13.1 Recombinant Human Growth Hormone Industry Trends
13.2 Recombinant Human Growth Hormone 麻豆原创 Drivers
13.3 Recombinant Human Growth Hormone 麻豆原创 Challenges
13.4 Recombinant Human Growth Hormone 麻豆原创 Restraints
14 Key Findings in The Global Recombinant Human Growth Hormone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F.Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
BioPartners
听
听
*If Applicable.